Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B
| Ano de defesa: | 2017 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Universidade Federal do Triângulo Mineiro
|
| Programa de Pós-Graduação: |
Programa de Pós-Graduação em Ciências da Saúde
|
| Departamento: |
Instituto de Ciências da Saúde - ICS::Programa de Pós-Graduação em Ciências da Saúde
|
| País: |
Brasil
|
| Palavras-chave em Português: | |
| Palavras-chave em Inglês: | |
| Área do conhecimento CNPq: | |
| Link de acesso: | http://bdtd.uftm.edu.br/handle/tede/646 |
Resumo: | Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is a reality. Interferons (IFNs) are glycoproteins that belong to the family of cytokines, which have an important antiviral, antitumor, immunomodulatory and antiangiogenic activities. The objective of this study was to determine which immunological profile (Th1 or Th2) could be involved in high-grade cervical lesions (CIN II / CIN III) through the serial dosing of cytokines by the Elisa method collected from peripheral blood samples in patients during a six weekly treatment with subcutaneously administered Pegylate 2-b IFN. The profile of the responses were analyzed in three blood samples and the cytokines of IL-1ᵦ, IL-2, IL-4, TNF-α I N-γ IL-10, IL-12, TGF-beta , IL-12. The analyzed groups were divided into good and bad response and were compared using non-parametric methods using the Mann-Whitney test, Wilcoxon Matched Paires test and Kruskal-Wallis test by GraphPad Prism 6® software, and the values observed for significance with P less than 0.05 (p <0.05). The results show that in the regression group the patients presented a increase in the amount of IFN-γ w =0,0123. On the other side, also showed an increase of IL-6, IL-10 and TGF (Th2 profile) in the group without a responde. In the general sample (n = 17), there was a 47% regression of high-grade lesions. Concluded that the regression of the lesions depends on the immunological profile of each patient as well as the change in the immune response to a Th1 profile. |
| id |
UFTM_80fecb109567d5249df56f43bd213682 |
|---|---|
| oai_identifier_str |
oai:bdtd.uftm.edu.br:tede/646 |
| network_acronym_str |
UFTM |
| network_name_str |
Biblioteca Digital de Teses e Dissertações da UFTM |
| repository_id_str |
|
| spelling |
MURTA, Eddie Fernando Candidohttp://lattes.cnpq.br/5724192420139830http://lattes.cnpq.br/7490788160201168TROVÓ, Marco Aurélio2019-05-06T12:58:39Z2017-04-17TROVÓ, Marco Aurélio. Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B. 2017. 86f. Dissertação (Mestrado em Ciências da Saúde) - Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Triângulo Mineiro, Uberaba, 2017.http://bdtd.uftm.edu.br/handle/tede/646Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is a reality. Interferons (IFNs) are glycoproteins that belong to the family of cytokines, which have an important antiviral, antitumor, immunomodulatory and antiangiogenic activities. The objective of this study was to determine which immunological profile (Th1 or Th2) could be involved in high-grade cervical lesions (CIN II / CIN III) through the serial dosing of cytokines by the Elisa method collected from peripheral blood samples in patients during a six weekly treatment with subcutaneously administered Pegylate 2-b IFN. The profile of the responses were analyzed in three blood samples and the cytokines of IL-1ᵦ, IL-2, IL-4, TNF-α I N-γ IL-10, IL-12, TGF-beta , IL-12. The analyzed groups were divided into good and bad response and were compared using non-parametric methods using the Mann-Whitney test, Wilcoxon Matched Paires test and Kruskal-Wallis test by GraphPad Prism 6® software, and the values observed for significance with P less than 0.05 (p <0.05). The results show that in the regression group the patients presented a increase in the amount of IFN-γ w =0,0123. On the other side, also showed an increase of IL-6, IL-10 and TGF (Th2 profile) in the group without a responde. In the general sample (n = 17), there was a 47% regression of high-grade lesions. Concluded that the regression of the lesions depends on the immunological profile of each patient as well as the change in the immune response to a Th1 profile.A imunoterapia em pacientes com câncer é um tratamento muito promissor e o desenvolvimento de novos protocolos e o estudo dos mecanismos de regressão é uma realidade. Os interferons (IFNs) são glicoproteínas pertencentes à família das citocinas que por sua vez desempenham importante ação antiviral, antitumoral, imunomoduladora e atividades antiangiogênicas. Objetivo é traçar os perfis imunológicos Th1 e Th2 envolvidos em lesões cervicais de alto grau NIC II/NIC III por dosagem sérica de citocinas pelo método de Elisa em amostras de soro colhidos durante o tratamento por 6 semanas com IFN Peguilado 2-b administrado por via subcutânea. O perfil de resposta das pacientes foram analizadas em três intervalos de coleta sanguínea e avaliadas as citocinas IL-1ᵦ, IL-2, IL-4, TNF-a, IFN-y, IL-10, IL-12, TGF-beta, IL-12. Os grupos de análise foram divididos em boa e má resposta e comparados utilizando-se a mediana por Mann-Whitney test, Wilcoxon Matched Paires test e Kruskal-Wallis test pelo software GraphPad Prism 6®, e os valores de p menores que 0,05 (p<0.05) foram considerados estatisticamente significantes. Os resultados mostram que no grupo que houve regressão os pacientes apresentaram um aumento na quantidade de IFN-γ durante toda a imunoterapia, com significância estatística p=0,0123. Por outro lado, também mostrou um aumento da IL-6, IL-10 e TGF (perfil Th2) no grupo sem resposta. Amostra geral (n=17), houve uma regressão de 47% das lesões de alto grau. Concluimos que a regressão das lesões cervicais depende do perfil imunológico de cada paciente como também as mudanças nas respostas imune para um perfil Th1.application/pdfhttp://bdtd.uftm.edu.br/retrieve/4018/Dissert%20Marco%20A%20Trovo.pdf.jpgporUniversidade Federal do Triângulo MineiroPrograma de Pós-Graduação em Ciências da SaúdeUFTMBrasilInstituto de Ciências da Saúde - ICS::Programa de Pós-Graduação em Ciências da Saúdehttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessImunoterapia.Neoplasia intraepitelial cervica.Interleucinas.Immunotherapy.Cervical intraepithelial neoplasia.Interleukins.ImunoterapiaDosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-Binfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisreponame:Biblioteca Digital de Teses e Dissertações da UFTMinstname:Universidade Federal do Triangulo Mineiro (UFTM)instacron:UFTMLICENSElicense.txtlicense.txttext/plain; charset=utf-81976http://bdtd.uftm.edu.br/bitstream/tede/646/1/license.txt1e1650138dd271baea0105346966c99cMD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://bdtd.uftm.edu.br/bitstream/tede/646/2/license_url4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80http://bdtd.uftm.edu.br/bitstream/tede/646/3/license_textd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://bdtd.uftm.edu.br/bitstream/tede/646/4/license_rdfd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALDissert Marco A Trovo.pdfDissert Marco A Trovo.pdfDissert Marco A Trovoapplication/pdf2197967http://bdtd.uftm.edu.br/bitstream/tede/646/5/Dissert%20Marco%20A%20Trovo.pdf1c48f68016390c279f5ddb5566976e54MD55TEXTDissert Marco A Trovo.pdf.txtDissert Marco A Trovo.pdf.txtExtracted Texttext/plain133163http://bdtd.uftm.edu.br/bitstream/tede/646/6/Dissert%20Marco%20A%20Trovo.pdf.txt68a880be4b4427fb67155a6435277cfbMD56THUMBNAILDissert Marco A Trovo.pdf.jpgDissert Marco A Trovo.pdf.jpgGenerated Thumbnailimage/jpeg1954http://bdtd.uftm.edu.br/bitstream/tede/646/7/Dissert%20Marco%20A%20Trovo.pdf.jpga8c0fa900a1e54d69b435465e2fd7e82MD57tede/6462019-05-07 01:00:16.467oai:bdtd.uftm.edu.br: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Biblioteca Digital de Teses e Dissertaçõeshttp://bdtd.uftm.edu.br/PUBhttp://bdtd.uftm.edu.br/oai/requestbdtd@uftm.edu.br||bdtd@uftm.edu.bropendoar:2019-05-07T04:00:16Biblioteca Digital de Teses e Dissertações da UFTM - Universidade Federal do Triangulo Mineiro (UFTM)false |
| dc.title.por.fl_str_mv |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B |
| title |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B |
| spellingShingle |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B TROVÓ, Marco Aurélio Imunoterapia. Neoplasia intraepitelial cervica. Interleucinas. Immunotherapy. Cervical intraepithelial neoplasia. Interleukins. Imunoterapia |
| title_short |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B |
| title_full |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B |
| title_fullStr |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B |
| title_full_unstemmed |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B |
| title_sort |
Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B |
| author |
TROVÓ, Marco Aurélio |
| author_facet |
TROVÓ, Marco Aurélio |
| author_role |
author |
| dc.contributor.advisor1.fl_str_mv |
MURTA, Eddie Fernando Candido |
| dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/5724192420139830 |
| dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/7490788160201168 |
| dc.contributor.author.fl_str_mv |
TROVÓ, Marco Aurélio |
| contributor_str_mv |
MURTA, Eddie Fernando Candido |
| dc.subject.por.fl_str_mv |
Imunoterapia. Neoplasia intraepitelial cervica. Interleucinas. |
| topic |
Imunoterapia. Neoplasia intraepitelial cervica. Interleucinas. Immunotherapy. Cervical intraepithelial neoplasia. Interleukins. Imunoterapia |
| dc.subject.eng.fl_str_mv |
Immunotherapy. Cervical intraepithelial neoplasia. Interleukins. |
| dc.subject.cnpq.fl_str_mv |
Imunoterapia |
| description |
Immunotherapy in cancer patients is a very promising treatment and the development of new protocols and the study of the mechanisms of regression is a reality. Interferons (IFNs) are glycoproteins that belong to the family of cytokines, which have an important antiviral, antitumor, immunomodulatory and antiangiogenic activities. The objective of this study was to determine which immunological profile (Th1 or Th2) could be involved in high-grade cervical lesions (CIN II / CIN III) through the serial dosing of cytokines by the Elisa method collected from peripheral blood samples in patients during a six weekly treatment with subcutaneously administered Pegylate 2-b IFN. The profile of the responses were analyzed in three blood samples and the cytokines of IL-1ᵦ, IL-2, IL-4, TNF-α I N-γ IL-10, IL-12, TGF-beta , IL-12. The analyzed groups were divided into good and bad response and were compared using non-parametric methods using the Mann-Whitney test, Wilcoxon Matched Paires test and Kruskal-Wallis test by GraphPad Prism 6® software, and the values observed for significance with P less than 0.05 (p <0.05). The results show that in the regression group the patients presented a increase in the amount of IFN-γ w =0,0123. On the other side, also showed an increase of IL-6, IL-10 and TGF (Th2 profile) in the group without a responde. In the general sample (n = 17), there was a 47% regression of high-grade lesions. Concluded that the regression of the lesions depends on the immunological profile of each patient as well as the change in the immune response to a Th1 profile. |
| publishDate |
2017 |
| dc.date.issued.fl_str_mv |
2017-04-17 |
| dc.date.accessioned.fl_str_mv |
2019-05-06T12:58:39Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
TROVÓ, Marco Aurélio. Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B. 2017. 86f. Dissertação (Mestrado em Ciências da Saúde) - Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Triângulo Mineiro, Uberaba, 2017. |
| dc.identifier.uri.fl_str_mv |
http://bdtd.uftm.edu.br/handle/tede/646 |
| identifier_str_mv |
TROVÓ, Marco Aurélio. Dosagem dos níveis séricos de citocinas em pacientes com neoplasia intra-epitelial cervival grau II e III tratados com Interferon perguilado 2-B. 2017. 86f. Dissertação (Mestrado em Ciências da Saúde) - Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal do Triângulo Mineiro, Uberaba, 2017. |
| url |
http://bdtd.uftm.edu.br/handle/tede/646 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Federal do Triângulo Mineiro |
| dc.publisher.program.fl_str_mv |
Programa de Pós-Graduação em Ciências da Saúde |
| dc.publisher.initials.fl_str_mv |
UFTM |
| dc.publisher.country.fl_str_mv |
Brasil |
| dc.publisher.department.fl_str_mv |
Instituto de Ciências da Saúde - ICS::Programa de Pós-Graduação em Ciências da Saúde |
| publisher.none.fl_str_mv |
Universidade Federal do Triângulo Mineiro |
| dc.source.none.fl_str_mv |
reponame:Biblioteca Digital de Teses e Dissertações da UFTM instname:Universidade Federal do Triangulo Mineiro (UFTM) instacron:UFTM |
| instname_str |
Universidade Federal do Triangulo Mineiro (UFTM) |
| instacron_str |
UFTM |
| institution |
UFTM |
| reponame_str |
Biblioteca Digital de Teses e Dissertações da UFTM |
| collection |
Biblioteca Digital de Teses e Dissertações da UFTM |
| bitstream.url.fl_str_mv |
http://bdtd.uftm.edu.br/bitstream/tede/646/1/license.txt http://bdtd.uftm.edu.br/bitstream/tede/646/2/license_url http://bdtd.uftm.edu.br/bitstream/tede/646/3/license_text http://bdtd.uftm.edu.br/bitstream/tede/646/4/license_rdf http://bdtd.uftm.edu.br/bitstream/tede/646/5/Dissert%20Marco%20A%20Trovo.pdf http://bdtd.uftm.edu.br/bitstream/tede/646/6/Dissert%20Marco%20A%20Trovo.pdf.txt http://bdtd.uftm.edu.br/bitstream/tede/646/7/Dissert%20Marco%20A%20Trovo.pdf.jpg |
| bitstream.checksum.fl_str_mv |
1e1650138dd271baea0105346966c99c 4afdbb8c545fd630ea7db775da747b2f d41d8cd98f00b204e9800998ecf8427e d41d8cd98f00b204e9800998ecf8427e 1c48f68016390c279f5ddb5566976e54 68a880be4b4427fb67155a6435277cfb a8c0fa900a1e54d69b435465e2fd7e82 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Biblioteca Digital de Teses e Dissertações da UFTM - Universidade Federal do Triangulo Mineiro (UFTM) |
| repository.mail.fl_str_mv |
bdtd@uftm.edu.br||bdtd@uftm.edu.br |
| _version_ |
1865641840895590400 |